A: Agilent Tech Price to Sales

Brandmark of Agilent Corp (A)

Agilent Technologies generates revenue through the supply of precision instruments and software for the pharmaceutical sector and laboratories. The smoothed P/S ratio for the company on the GURU.Markets daily chart reflects current dynamics, with the current value standing at 6.60. Moderate electronics outsourcing combined with in-house R&D minimizes risks, while strategic continuity following the CEO transition sustains steady investor optimism.

A (Agilent Corp) Market Cap to Revenue history from 07/04/2022 to 11/13/2026

Agilent Tech (A) - metric breakdowns and financial figures

- current price and projected stock value:
Price Chart agilent.com|A - Analyst Consensus Forecast
- market capitalization information:
Market Value Agilent Tech|A - Total Company Value
- shareholders' equity book value data:
Equity per Share Agilent|A - Company Net Assets|Market Cap to Book Value Multiple agilent.com|A - Cumulative Company Assets
- issuer credit burden and liquidity indicators:
All Debt to Shareholders' Equity Ratio Agilent Technologies|A - Long-Term Debt to Equity Ratio|Short-Term Loans to Capital Ratio Agilent Corp|A - Company Aggregate Debts|Debts to Book Value Agilent Tech|A - Company Long-Term Debts|Company Current Liabilities Agilent|Intermediate Coverage Ratio agilent.com
- net income and valuation multiples indicators:
A - Company Net Income|Net Profit Forecast Agilent Technologies|A - Price to Earnings Ratio|Projected Price to Earnings Ratio Agilent Technologies, Inc.|A - Price/Earnings to Growth Ratio|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Agilent Tech|A - Profit before payment of interest, taxes and amortization|Net earnings per one share for the last twelve months Agilent|A - Net earnings per share (EPS TTM)|Net earnings per share growth for the trailing year agilent.com|A - Earnings growth in current year|Consensus forecast of earnings per share growth for next year Agilent Technologies
- sales revenue and business income indicators:
A - Revenue and Sales Volume|Company Expected Sales Volume agilent.com|A - Price-to-Revenue Ratio|Market Cap to Expected Sales Ratio Agilent Tech
General company analysis:A - agilent.com
Finished products of Agilent Technologies, Inc.

Agilent Technologies' leadership in environmental sustainability and the transition to renewable energy create long-term value, which the market assesses via the price-to-sales ratio. By analyzing the fundamental P/S, an investor determines how many dollars of business value are attributed to each unit of revenue, allowing for an assessment of the premium paid for "green" technologies and the determination of the fair cost of capital.

Competing companies

Price-to-Revenue Ratio DGX (questdiagnostics.com)|P/S Multiple ILMN (Illumina)|Exact Sciences Corp (EXAS) - Price to Sales|RVTY - Price-to-Revenue Ratio|BIO (Bio-Rad Corp) - Market Cap to Revenue Ratio|NNNN (Anbio Biotechnology) - Market Cap to Revenue|SHC: Market Cap to Sales Volume|Market Cap to Revenue QDEL|OPK: Market Capitalization-to-Revenue Ratio|Market Cap to Revenue CDNA (CareDx Corp)|Market Cap to Sales Volume MRVI|P/S Multiple FLGT (Fulgent Genetics, Inc.)|fluidigm.com (LAB) - Price to Sales|Cytek Biosciences - P/S Multiple|OraSure Technologies, Inc. (OSUR) - Market Cap to Revenue|XGN: P/S Multiple|MDxHealth, Inc. - Market Capitalization-to-Revenue Ratio|Price-to-Revenue Ratio Lucid Diagnostics Inc.|Market Cap to Revenue Ratio PRE (Prenetics Global Ltd)|Price-to-Revenue Ratio Insight Molecular Diagnostics (IMDX)|TRIB - Price to Sales|Price-to-Revenue Ratio ProPhase PRPH|Ainos Corporation - Price-to-Revenue Ratio|CODX - Price-to-Revenue Ratio|Price to Sales heartsciences.com|BMRA: P/S Multiple|Price-to-Revenue Multiple Cardio Diagnostics Holdings CDIO|ONCO (Onconetix Corp) - P/S Multiple|Virax Biolabs Corp (VRAX) - Price-to-Revenue Coefficient|P/S Multiple BJDX|AWH - Price to Sales|Price-to-Revenue Ratio Accelerate Diagnostics, Inc. AXDX|Price-to-Revenue Coefficient Centogene N.V. (CNTG)|Enzo - P/S Multiple|FRES - P/S Multiple|gtglabs.com (GENE) - Price-to-Revenue Ratio|Market Cap to Revenue 23andme.com|PMD (Psychemedics Corporation) - P/S Multiple